Talphera (TLPH) Acquisitions (2021 - 2022)

Talphera (TLPH) posted quarterly Acquisitions of $531000.0 for Q2 2022, down 54.07% quarter-over-quarter from $1.2 million in Q1 2022.

Talphera (TLPH) Acquisitions (2021 - 2022) Analysis & Trends

Talphera's Acquisitions history runs 2 years deep, the most recent figure standing at $531000.0 for Q2 2022.

In Q2 2022, Acquisitions changed N/A year-over-year to $531000.0; the TTM figure through Mar 2023 stood at $531000.0 (down 73.14% YoY), while the FY2022 annual figure was $1.7 million, up 105.48% from the prior year.
Acquisitions for Q2 2022 stood at $531000.0, down from $1.2 million in the prior quarter.
The five-year high for Acquisitions was $1.2 million in Q1 2022, with the low at $531000.0 in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn	-
3	Zoetis	31.53 Bn	29.85 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn	-
5	United Therapeutics	22.13 Bn	19.47 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-	-
10	Talphera	90.25 Mn	90.25 Mn	-	-

Download Data